tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Swapnil Malekar, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).
Analyst Swapnil Malekar, currently employed carries an average stock price target met ratio of 17.5% that have a potential upside of 9.73% achieved within 14 days.
Swapnil Malekar’s has documented 27 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MRTX, Mirati Ther at 09-Aug-2023.
Analyst best performing recommendations are on NGM (NGM BIOPHARMACEUTICALS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.55
$0.01 (0.65%)
$9
8 months 20 days ago
(28-Feb-2024)
4/6 (66.67%)
$0.02 (1.31%)
233
Buy
$3.5
$1.96 (127.27%)
$7
11 months 26 days ago
(22-Nov-2023)
3/9 (33.33%)
$2.79 (392.96%)
262
Buy
$3.5
$1.96 (127.27%)
$7
11 months 26 days ago
(22-Nov-2023)
0/2 (0%)
$2.79 (392.96%)
Buy
$6
$4.46 (289.61%)
$4
2 years 13 days ago
(04-Nov-2022)
1/8 (12.5%)
$0.64 (11.94%)
3
Hold
$30
2 years 1 months ago
(17-Oct-2022)
2/3 (66.67%)
$4.64 (18.30%)
123
What Year was the first public recommendation made by Swapnil Malekar?
